GSK plc 13F holdings
GSK plc reported 13 positions with a total reported value of $602.2M as of 2026-06-30, in its 13F for Q2 2026, filed 2026-08-13. Top holdings by reported value: CRSP CRISPR THERAPEUTICS AG (29.2%), WVE WAVE LIFE SCIENCES LTD (17.6%), VIR VIR BIOTECHNOLOGY INC (14.5%), BNTX BIONTECH SE (13.7%), IDYA IDEAYA BIOSCIENCES INC (8.3%). Against 2026-03-31 it opened 0 new positions and exited 0. Next 13F due by 2026-11-14, the legal deadline 45 days after the quarter ending 2026-09-30.
Email me when GSK plc files its 13F
A free account follows up to 10 funds. New 13F filings arrive in your daily or weekly digest. No password and no card.
Top holdings
| Holding | Shares | Reported value | % of portfolio |
|---|---|---|---|
| CRSP CRISPR THERAPEUTICS AG | 3,220,627 | $175.7M | 29.2% |
| WVE WAVE LIFE SCIENCES LTD | 18,245,691 | $106.0M | 17.6% |
| VIR VIR BIOTECHNOLOGY INC | 8,550,954 | $87.1M | 14.5% |
| BNTX BIONTECH SE | 889,824 | $82.8M | 13.7% |
| IDYA IDEAYA BIOSCIENCES INC | 1,333,333 | $49.7M | 8.3% |
| CYTK CYTOKINETICS INC | 340,434 | $29.0M | 4.8% |
| LYEL LYELL IMMUNOPHARMA INC | 1,512,659 | $21.3M | 3.5% |
| SPRO SPERO THERAPEUTICS INC | 9,190,606 | $20.3M | 3.4% |
| NKTX NKARTA INC | 3,150,732 | $8.9M | 1.5% |
| FULC FULCRUM THERAPEUTICS INC | 1,785,714 | $6.5M | 1.1% |
| BCYC BICYCLE THERAPEUTICS PLC | 1,529,561 | $6.5M | 1.1% |
| CVRX CVRX INC | 1,007,583 | $5.2M | 0.9% |
| RGNX REGENXBIO INC | 271,456 | $3.3M | 0.5% |
New positions this quarter
No new positions.
Sold out
No positions were sold out.
Biggest increases and decreases
Increases
No position was increased.
Decreases
No position was decreased.

